Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05DSS
|
|||
| Former ID |
DNCL003560
|
|||
| Drug Name |
GI-13020
|
|||
| Synonyms |
Tarmogen (TN)
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 1 | [1] | |
| Company |
GlobeImmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01779505) A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.